Strides completes US FDA inspection at its Alathur facility
The company announced a successful completion of inspection at the facility by US FDA with “Zero 483 observations”
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Strides Pharma Science
7th Pharma Pro & Pack Expo held in Bangaluru
During a panel discussion, experts discussed about new technologies, challenges in incorporating quality and compliance. It was…
Sangita Reddy to step down as independent director: Strides Pharma
"Sangita was appointed as an independent director of the company for a period of five years at the 23rd annual general meeting…
Newer technology will disrupt the pharma manufacturing process
During the panel discussion experts discusses about New technologies: Challenges in incorporating quality and compliance. It was…
Strides inks JV pact with China’s Sihuan Pharma, releases Q1FY20 performance report
Strides also announced Q1FY20 revenues at Rs 6,888mn demonstrating a 44 per cent YoY and 11 per cent QoQ growth
US FDA completes inspection of Strides Pharma Bengaluru plant
The company's facility in Bengaluru underwent a United States Food and Drug Administration (US FDA) inspection that ended on May…
Panel discussion: Futuristic formulation development and drug delivery technologies
The third edition of the FDD Conclave witnessed several interesting discussions on topics which are very pertinent to the…
Strides Pharma Puducherry unit receives warning letter from US FDA
The drug firm, however, did not provide any details of the contents of the warning letter received from the regulator